164 related articles for article (PubMed ID: 23484071)
1. Effective combination of photodynamic therapy and imiquimod 5% cream in the treatment of actinic keratoses: three cases.
Held L; Eigentler TK; Leiter U; Garbe C; Berneburg MJ
Biomed Res Int; 2013; 2013():102698. PubMed ID: 23484071
[TBL] [Abstract][Full Text] [Related]
2. Treatment of actinic keratoses with sequential use of photodynamic therapy; and imiquimod 5% cream.
Shaffelburg M
J Drugs Dermatol; 2009 Jan; 8(1):35-9. PubMed ID: 19180894
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3 multicenter, randomized, double-blind, placebo-controlled studies.
Swanson N; Smith CC; Kaur M; Goldenberg G
J Drugs Dermatol; 2013 Nov; 12(11):1278-82. PubMed ID: 24196337
[TBL] [Abstract][Full Text] [Related]
4. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Swanson N; Smith CC; Kaur M; Goldenberg G
J Drugs Dermatol; 2014 Feb; 13(2):166-9. PubMed ID: 24509967
[TBL] [Abstract][Full Text] [Related]
5. Open-label study to assess the safety and efficacy of imiquimod 5% cream applied once daily three times per week in cycles for treatment of actinic keratoses on the head.
Rivers JK; Rosoph L; Provost N; Bissonnette R
J Cutan Med Surg; 2008; 12(3):97-101. PubMed ID: 18544290
[TBL] [Abstract][Full Text] [Related]
6. Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial.
Gebauer K; Shumack S; Cowen PS
Br J Dermatol; 2009 Oct; 161(4):897-903. PubMed ID: 19545297
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod 3.75% cream (Zyclara) for the treatment of actinic keratoses.
Quist SR; Gollnick HP
Expert Opin Pharmacother; 2011 Feb; 12(3):451-61. PubMed ID: 21254950
[TBL] [Abstract][Full Text] [Related]
8. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.
Sotiriou E; Apalla Z; Maliamani F; Zaparas N; Panagiotidou D; Ioannides D
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1061-5. PubMed ID: 19470041
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses.
Stockfleth E; Meyer T; Benninghoff B; Salasche S; Papadopoulos L; Ulrich C; Christophers E
Arch Dermatol; 2002 Nov; 138(11):1498-502. PubMed ID: 12437457
[TBL] [Abstract][Full Text] [Related]
10. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials.
Lebwohl M; Dinehart S; Whiting D; Lee PK; Tawfik N; Jorizzo J; Lee JH; Fox TL
J Am Acad Dermatol; 2004 May; 50(5):714-21. PubMed ID: 15097955
[TBL] [Abstract][Full Text] [Related]
11. Treatment of actinic keratoses with 5% topical imiquimod: a multicenter prospective observational study from 93 Austrian office-based dermatologists.
Strohal R; Kerl H; Schuster L
J Drugs Dermatol; 2012 May; 11(5):574-8. PubMed ID: 22527424
[TBL] [Abstract][Full Text] [Related]
12. Comparative study for the effect of photodynamic therapy, imiquimod immunotherapy and combination of both therapies on 40 lesions of actinic keratosis in Japanese patients.
Tanaka N; Ohata C; Ishii N; Imamura K; Ueda A; Furumura M; Yasumoto S; Kawakami T; Tsuruta D; Hashimoto T
J Dermatol; 2013 Dec; 40(12):962-7. PubMed ID: 24147543
[TBL] [Abstract][Full Text] [Related]
13. Imiquimod cream in the treatment of actinic keratoses.
Persaud A; Lebwohl M
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S236-9. PubMed ID: 12271285
[TBL] [Abstract][Full Text] [Related]
14. Results of an investigator-initiated single-blind split-face comparison of photodynamic therapy and 5% imiquimod cream for the treatment of actinic keratoses.
Hadley J; Tristani-Firouzi P; Hull C; Florell S; Cotter M; Hadley M
Dermatol Surg; 2012 May; 38(5):722-7. PubMed ID: 22340282
[TBL] [Abstract][Full Text] [Related]
15. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles.
Swanson N; Abramovits W; Berman B; Kulp J; Rigel DS; Levy S
J Am Acad Dermatol; 2010 Apr; 62(4):582-90. PubMed ID: 20133013
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series.
Tambone S; Fargnoli MC; Capizzi R; Peris K
G Ital Dermatol Venereol; 2018 Jun; 153(3):333-337. PubMed ID: 26439591
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses.
Jorizzo JL; Markowitz O; Lebwohl MG; Bourcier M; Kulp J; Meng TC; Levy S
J Drugs Dermatol; 2010 Sep; 9(9):1101-8. PubMed ID: 20865842
[TBL] [Abstract][Full Text] [Related]
18. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles.
Hanke CW; Beer KR; Stockfleth E; Wu J; Rosen T; Levy S
J Am Acad Dermatol; 2010 Apr; 62(4):573-81. PubMed ID: 20133012
[TBL] [Abstract][Full Text] [Related]
19. Placebo-controlled, double-blind, randomized pilot study of imiquimod 5% cream applied once per week for 6 months for the treatment of actinic keratoses.
Zeichner JA; Stern DW; Uliasz A; Itenberg S; Lebwohl M
J Am Acad Dermatol; 2009 Jan; 60(1):59-62. PubMed ID: 18937999
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis.
Kose O; Koc E; Erbil AH; Caliskan E; Kurumlu Z
J Dermatolog Treat; 2008; 19(3):159-63. PubMed ID: 18569272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
